The Nightview Fund Q1 2026 Investor Letter

AXON looks more interesting as a flow and positioning story than as a pure fundamentals call. In a broad software de-risking tape, names with defensible growth and mission-critical end markets tend to get sold indiscriminately first, then re-rated fastest once the marginal seller is exhausted; that usually creates a short, violent dislocation rather than a multi-quarter thesis break. The key second-order effect is that high-quality secular compounders can absorb capital from crowded software adjacency trades, so the stock can outperform simply because it becomes the cleanest way to express "growth without balance-sheet risk".

The main risk is that the market may be underestimating how long multiple compression can persist if factor pressure remains dominant. In the near term, any continuation of higher real yields or risk-off flows could cap upside even if company execution remains intact, meaning the stock may need time rather than a catalyst to work. The reversal trigger is likely not a headline, but stabilization in software basket breadth and a reduction in forced selling from momentum/systematic funds over the next 2-6 weeks.

The contrarian view is that the selloff may be less about the company and more about crowded ownership plus valuation fragility. That means the opportunity is best expressed tactically: the stock can re-rate sharply if it reclaims relative strength, but chasing immediately after a sharp correction risks buying before the de-grossing finishes. A cleaner setup would be to wait for confirmation that the broader software complex has stopped making new lows, then use AXON as a quality-leader long rather than a mean-reversion punt.